Health Care & Life Sciences » Pharmaceuticals | Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc. | Balance Sheet

Fiscal year is December-November. All values CAD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
805.20
4,827.80
2,337.30
5,572.60
2,444.00
Total Accounts Receivable
1,752.50
1,523.50
1,247.40
1,551.10
1,708.40
Inventories
-
-
-
-
149.00
Other Current Assets
330.90
472.80
305.20
538.70
290.00
Total Current Assets
2,888.60
6,824.10
3,889.90
7,662.40
4,591.40
Net Property, Plant & Equipment
1,303.60
1,845.90
2,343.00
2,540.80
4,209.60
Other Assets
-
309.40
724.10
519.50
728.30
Total Assets
4,636.60
8,979.50
6,956.90
10,722.80
9,529.30
ST Debt & Current Portion LT Debt
821.90
1,594.90
2,049.30
2,029.80
1,662.50
Accounts Payable
858.00
761.80
4,032.20
1,085.50
2,654.00
Other Current Liabilities
1,275.20
976.80
838.20
2,526.60
1,671.40
Total Current Liabilities
2,955.00
3,333.50
6,919.70
5,641.80
5,987.90
Long-Term Debt
2,229.00
48.10
20.90
-
-
Deferred Taxes
444.40
-
-
-
-
Other Liabilities
5,757.20
-
199.80
3,580.00
3,043.60
Total Liabilities
10,941.20
3,381.60
7,140.30
9,221.80
9,031.50
Common Equity (Total)
6,304.60
5,597.90
183.40
1,500.90
497.80
Total Shareholders' Equity
6,304.60
5,597.90
183.40
1,500.90
497.80
Total Equity
6,304.60
5,597.90
183.40
1,500.90
497.80
Liabilities & Shareholders' Equity
4,636.60
8,979.50
6,956.90
10,722.80
9,529.30

About Intellipharmaceutics International

View Profile
Address
30 Worcester Road
Toronto Ontario M9W 5X2
Canada
Employees -
Website http://www.intellipharmaceutics.com
Updated 09/14/2018
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi on October 22, 2009 and is headquartered in Toronto, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.